Placental mesenchymal stem cells of fetal origin deposit epigenetic alterations during long-term culture under serum-free condition

Bibliography

• Das M, Sundell IB, Koka PS. Adult mesenchymal stem cells and their potency in the cell-based therapy. J Stem Cells 2013;8:1-16
   PubMedGoogle Scholar
• Fierabracci A, Del Fattore A, Luciano R, et al. Recent advances in mesenchymal stem cell immunomodulation. the role of microvesicles. Cell Transplant 2013. [Epub ahead of print]
   Web of Science ®Google Scholar
• Zhang C, Zhai W, Xie Y, et al. Mesenchymal stem cells derived from breast cancer tissue promote the proliferation and migration of the MCF-7 cell line. Oncol Lett 2013;6:1577-82
   PubMed Web of Science ®Google Scholar
• Wagner W, Horn P, Castoldi M, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 2008;3:e2213
   PubMed Web of Science ®Google Scholar
• Li H, Fan X, Kovi RC, et al. Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res 2007;67:10889-98
   PubMed Web of Science ®Google Scholar
• Miura M, Miura Y, Padilla-Nash HM, et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 2006;24:1095-103
   PubMed Web of Science ®Google Scholar
• Gou S, Wang C, Liu T, et al. Spontaneous differentiation of murine bone marrow-derived mesenchymal stem cells into adipocytes without malignant transformation after long-term culture. Cells Tissues Organs 2010;191:185-92
   PubMed Web of Science ®Google Scholar
• Tang Q, Chen Q, Lai X, et al. Malignant transformation potentials of human umbilical cord mesenchymal stem cells both spontaneously and via 3-methycholanthrene induction. PLoS One 2013;8:e81844
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Z, Chi Y, et al. Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation. Cell Death Dis 2013;4:e950
   PubMed Web of Science ®Google Scholar
• Redaelli S, Bentivegna A, Foudah D, et al. From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther 2012;3:47
   PubMedGoogle Scholar
• Schellenberg A, Lin Q, Schuler H, et al. Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging 2011;3:873-88
   PubMedGoogle Scholar
• Colosimo A, Russo V, Mauro A, et al. Prolonged in vitro expansion partially affects phenotypic features and osteogenic potential of ovine amniotic fluid-derived mesenchymal stromal cells. Cytotherapy 2013;15:930-50
   PubMed Web of Science ®Google Scholar
• Choi MR, In YH, Park J, et al. Genome-scale DNA methylation pattern profiling of human bone marrow mesenchymal stem cells in long-term culture. Exp Mol Med 2012;44:503-12
   PubMed Web of Science ®Google Scholar
• Binato R, de Souza Fernandez T, Lazzarotto-Silva C, et al. Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy. Cell Prolif 2013;46:10-22
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28
   PubMed Web of Science ®Google Scholar
• Langevin SM, Kratzke RA, Kelsey KT. Epigenetics of lung cancer. Transl Res 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Mummaneni P, Shord SS. Epigenetics and oncology. Pharmacotherapy 2014;34(5):495-505
   PubMed Web of Science ®Google Scholar
• Bork S, Pfister S, Witt H, et al. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 2010;9:54-63
   PubMed Web of Science ®Google Scholar
• Teng IW, Hou PC, Lee KD, et al. Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res 2011;71:4653-63
   PubMed Web of Science ®Google Scholar
• Kong P, Xie X, Li F, et al. Placenta mesenchymal stem cell accelerates wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki (GK) rats. Biochem Biophys Res Commun 2013;438:410-19
   PubMed Web of Science ®Google Scholar
• Parolini O, Alviano F, Bergwerf I, et al. Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells Dev 2010;19:143-54
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li C, Jiang X, et al. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells. Exp Hematol 2004;32:657-64
   PubMed Web of Science ®Google Scholar
• Sabapathy V, Ravi S, Srivastava V, et al. Long-term cultured human term placenta-derived mesenchymal stem cells of maternal origin displays plasticity. Stem Cells Int 2012;2012:174328
   PubMedGoogle Scholar
• Zhu Y, Yang Y, Zhang Y, et al. Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials. Stem Cell Res Ther 2014;5:48
   PubMedGoogle Scholar
• Wang L, Yang Y, Zhu Y, et al. Characterization of placenta-derived mesenchymal stem cells cultured in autologous human cord blood serum. Molecular Med Rep 2012;6:760-6
   Web of Science ®Google Scholar
• Li CD, Zhang WY, Li HL, et al. Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation. Cell Res 2005;15:539-47
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45
   PubMed Web of Science ®Google Scholar
• Hwang SM, See CJ, Choi J, et al. The application of an in situ karyotyping technique for mesenchymal stromal cells: a validation and comparison study with classical G-banding. Exp Mol Med 2013;45:e68
   PubMed Web of Science ®Google Scholar
• Barch MJ, Knutsen T, Spurbeck JL. The AGT cytogenetics laboratory manual. Lippincott-Raven; Philadelphia, PA, USA: 1997
   Google Scholar
• Gonzalez Garcia JR, Meza-Espinoza JP. Use of the international system for human cytogenetic nomenclature (ISCN). Blood 2006;108:3952-3. author reply 3
   PubMed Web of Science ®Google Scholar
• Beissbarth T, Speed TP. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 2004;20:1464-5
   PubMed Web of Science ®Google Scholar
• Chen AK, Reuveny S, Oh SK. Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction. Biotechnol Adv 2013;31:1032-46
   PubMed Web of Science ®Google Scholar
• Bellavia M, Altomare R, Cacciabaudo F, et al. Towards an ideal source of mesenchymal stem cell isolation for possible therapeutic application in regenerative medicine. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Wegmeyer H, Broske AM, Leddin M, et al. Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev 2013;22:2606-18
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Zaffaroni N, Novara F, et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007;67:9142-9
   PubMed Web of Science ®Google Scholar
• Bonab MM, Alimoghaddam K, Talebian F, et al. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006;7:14
   PubMed Web of Science ®Google Scholar
• Herberts CA, Kwa MS, Hermsen HP. Risk factors in the development of stem cell therapy. J transl Med 2011;9:29
   PubMed Web of Science ®Google Scholar
• Berdasco M, Esteller M. DNA methylation in stem cell renewal and multipotency. Stem Cell Res Ther 2011;2:42
   PubMedGoogle Scholar
• Sundin M, Ringden O, Sundberg B, et al. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 2007;92:1208-15
   PubMed Web of Science ®Google Scholar
• Tuschong L, Soenen SL, Blaese RM, et al. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 2002;13:1605-10
   PubMed Web of Science ®Google Scholar
• Berniakovich I, Giorgio M. Low oxygen tension maintains multipotency, whereas normoxia increases differentiation of mouse bone marrow stromal cells. Int J Mol Sci 2013;14:2119-34
   PubMed Web of Science ®Google Scholar
• Korbut E, Ptak-Belowska A, Brzozowski T. Mechanisms promoting physiological cells progression into tumorigenesis. J Physiol Pharmacol 2012;63:565-70
   PubMed Web of Science ®Google Scholar
• Mark P, Kleinsorge M, Gaebel R, et al. Human mesenchymal stem cells display reduced expression of cd105 after culture in serum-free medium. Stem Cells Int 2013;2013:698076
   PubMed Web of Science ®Google Scholar
• Syeda F, Fagan RL, Wean M, et al. The replication focus targeting sequence (RFTS) domain is a DNA-competitive inhibitor of Dnmt1. J Biol Chem 2011;286:15344-51
   PubMed Web of Science ®Google Scholar
• Lan J, Hua S, He X, et al. DNA methyltransferases and methyl-binding proteins of mammals. Acta Biochim Biophys Sin (Shanghai) 2010;42:243-52
   Google Scholar
• Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000;9:2395-402
   PubMed Web of Science ®Google Scholar
• Suetake I, Shinozaki F, Miyagawa J, et al. DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction. J Biol Chem 2004;279:27816-23
   PubMed Web of Science ®Google Scholar
• Jin B, Robertson KD. DNA methyltransferases, DNA damage repair, and cancer. Adv Exp Med Biol 2013;754:3-29
   PubMed Web of Science ®Google Scholar
• Turek-Plewa J, Jagodzinski PP. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 2005;10:631-47
   PubMed Web of Science ®Google Scholar
• Dansranjavin T, Krehl S, Mueller T, et al. The role of promoter CpG methylation in the epigenetic control of stem cell related genes during differentiation. Cell Cycle 2009;8:916-24
   PubMed Web of Science ®Google Scholar
• Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33(Suppl):245-54
   PubMed Web of Science ®Google Scholar
• Li N, Yang R, Zhang W, et al. Genetically transforming human mesenchymal stem cells to sarcomas: changes in cellular phenotype and multilineage differentiation potential. Cancer 2009;115:4795-806
   PubMed Web of Science ®Google Scholar
• Mohseny AB, Hogendoorn PC. Concise review: mesenchymal tumors: when stem cells go mad. Stem Cells 2011;29:397-403
   PubMed Web of Science ®Google Scholar
• Mohseny AB, Szuhai K, Romeo S, et al. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol 2009;219:294-305
   PubMed Web of Science ®Google Scholar
• Xiao W, Mohseny AB, Hogendoorn PC, et al. Mesenchymal stem cell transformation and sarcoma genesis. Clin Sarcoma Res 2013;3:10
   PubMedGoogle Scholar
• Zhang S, Han Z, Kong Q, et al. Malignant transformation of rat bone marrow-derived mesenchymal stem cells treated with 4-nitroquinoline 1-oxide. Chem Biol Interact 2010;188:119-26
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang Y, Bai L, et al. Rat bone marrow mesenchymal stem cells undergo malignant transformation via indirect co-cultured with tumour cells. Cell biochem Funct 2012;30:650-6
   PubMed Web of Science ®Google Scholar
• Sun Y, Yang Y, Zeng S, et al. Identification of proteins related to epigenetic regulation in the malignant transformation of aberrant karyotypic human embryonic stem cells by quantitative proteomics. PLoS One 2014;9:e85823
   PubMed Web of Science ®Google Scholar
• Rosland GV, Svendsen A, Torsvik A, et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 2009;69:5331-9
   PubMed Web of Science ®Google Scholar
• Torsvik A, Rosland GV, Svendsen A, et al. Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. Cancer Res 2010;70:6393-6
   PubMed Web of Science ®Google Scholar
• Sempere JM, Martinez-Peinado P, Arribas MI, et al. Single-Cell derived clones from human adipose stem cells present different immunomodulatory properties. Clin Exp Immunol 2014;176(2):255-65
   PubMed Web of Science ®Google Scholar
• Poloni A, Maurizi G, Babini L, et al. Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion. Cell Transpl 2011;20:643-54
   PubMed Web of Science ®Google Scholar
• Zhou XG, Yang Y, Yang JS, et al. Granulocyte-macrophage colony-stimulating factor and interleukin 4 induce the malignant transformation of the bone marrow-derived human adult mesenchymal stem cells. Chin Med J (Engl) 2011;124:729-33
   PubMed Web of Science ®Google Scholar